Regulatory Capital Instruments - Quarterly

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

General guidance
The Regulatory Capital Instruments annual (FR Y-14A) and quarterly (FR Y-14Q) schedules collect
historical data and projections of BHCs’ balances of the funded instruments that are included in
regulatory capital. The FR Y-14A annual schedule collects data on the historical balances and projected
balances of funded regulatory capital instruments by instrument type, in addition to projections for
issuances and redemptions that contribute to changes in balances under the BHC baseline scenario. The
FR Y-14Q quarterly schedule collects historical data at the CUSIP level on the balances of each funded
regulatory capital instrument, in addition to information on any issuances and redemptions of individual
instruments that occurred during the quarter.
Summary of changes from previous versions of the schedules
•

•

FR Y-14A annual schedule
o The Federal Reserve will no longer pre-populate the annual schedule with data on BHCs’
capital instruments previously collected during CCAR monitoring.
o The revised annual schedule no longer collects information on the balances and
proposed capital actions at the individual instrument level over the forecasted planning
horizon. The revised annual schedule collections information on the total balances of
capital instruments and on planned redemptions and issuances at an aggregate
instrument-type level (e.g., common stock, non-cumulative perpetual preferred,
subordinated debt, etc.).
o The revised annual schedule collects data to calculate the reconciliation of the balances
of funded capital instruments with balances for Tier 1, Tier 2, and Total Capital for the
entire nine quarter horizon of CCAR. The previous version of the schedule collected
data to calculate this reconciliation only as of 3Q2011.
FR Y-14Q quarterly schedule
o The Federal Reserve will no longer pre-populate the quarterly schedule with data on
BHCs’ capital instruments and planned actions previously collected during CCAR.
o The revised quarterly schedule collects information on BHCs’ inventory of capital
instruments as of the end of the most recent quarter. The previous version of the
schedule required each BHC to confirm pre-populated information on its capital stack as
of the end of the prior quarter.
o The revised quarterly schedule does not require BHCs to report changes in the balances
of capital instruments due to amortizations or accretions as either Redemptions or
Issuances.

1

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

FR Y-14A schedule instructions
Projected Capital Actions & Balances worksheet
This worksheet collects information on the current and projected balances of regulatory capital
instruments aggregated by instrument type over the nine quarter horizon. BHCs are to report
information on both a notional basis and on the basis of the dollar amount included in regulatory
capital.
•

•

•

Quarterly Redemption/Repurchase Activity – Report the actual and projected aggregate dollar
amount ($Millions) of redemptions/repurchases to be conducted in each quarter for each type
of capital instrument. All redemptions/repurchases should be reported as negative values. For
any instrument type that the BHC does not include in its reported regulatory capital or for which
there is no actual/planned redemption/repurchase activity during a particular quarter, please
enter “0” (zero).
Quarterly Issuance Activity – Report the actual and projected aggregate dollar amount
($Millions) of issuances to be conducted in each quarter for each type of capital instrument. For
any instrument type that the BHC does not include in its reported regulatory capital or for which
there is no planned issuance activity during a particular quarter, please enter “0” (zero).
Capital Balances – Input the actual and projected aggregate balances ($Millions) of each type of
capital instrument for the relevant quarter. For any instrument type the BHC does not include in
its reported regulatory capital, please enter “0” (zero).
o For Common Stock (Line 37), please report this value as the sum of “Common Stock (par
value)” (BHCK 3230) plus “Surplus” (BHCK 3240) LESS “Treasury Stock in the form of
Common Stock” (BHCK 5484) and LESS “Issuances associated with the U.S. Department
of Treasury Capital Purchase Program: Warrants to Purchase Common Stock” (BHCK
G235).

Capital Position Reconciliation worksheet
This worksheet combines information reported on the Projected Capital Actions & Balances worksheet
with additional data in order to reconcile the actual and projected balances of funded capital
instruments with the balances of regulatory Tier 1, Tier 2, and Total Capital as reported on form FR Y-9C
and on the FR Y-14A Summary schedule. Please ensure that the balances of Tier 1 Capital, Tier 2 Capital
and Total Capital as calculated on this worksheet are the same as those reported by your BHC on the FR
Y-14A Summary schedule.

2

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

FR Y-14Q Regulatory Capital Instruments schedule instructions
Regulatory Capital Instruments as of Quarter End worksheet
This worksheet collects historical information on the BHCs’ regulatory capital instruments as of the end
of the most recent quarter. Complete this worksheet with details on each of the funded capital
instruments your BHC includes in regulatory capital as of quarter end. For each instrument, provide the
following details:

Column

Heading

Description

B

Committee on Uniform
Securities and Identification
(CUSIP) or unique identifier
provided by BHC

Report the CUSIP number or unique identification number
assigned to the instrument as provided by the BHC.

C

Instrument type

Report the type of regulatory capital instrument. Instruments
should be reported based on whether they were included in
Tier 1 or Tier 2 regulatory capital.

D

Basel I treatment

Report the regulatory capital treatment for the instrument
under the Basel I rule set.

E

Expected Basel III treatment

Report the expected regulatory capital treatment for the
instrument as per Basel III NPR
(https://www.federalregister.gov/articles/2012/08/30/201216757/regulatory-capital-rules-regulatory-capitalimplementation-of-basel-iii-minimum-regulatory-capital).

F

Cumulative/noncumulative

Report whether the instrument’s coupon/dividend is
cumulative or noncumulative.

G

Notional amount ($Millions)

Report the notional dollar amount of the instrument as of
quarter end.

H

Amount recognized in
regulatory capital ($Millions)

Report the dollar amount of the instrument that qualified as
regulatory capital as of quarter end.

I

Comments

Use this field to report any supporting information regarding
the instrument.

3

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

Regulatory Capital Instrument Repurchases/Redemptions During Quarter worksheet
BHCs are to complete this worksheet with details on any repurchase or redemption activity for its capital
instruments during the quarter. For each instrument that was subject to a redemption or repurchase,
please provide the following details:

Column

Heading

Description

B

Committee on Uniform
Securities and Identification
(CUSIP) or unique identifier
provided by BHC

Report the CUSIP number or unique identification number
assigned to the instrument as provided by the BHC.

C

Instrument type

Report the type of regulatory capital instrument.

D

Basel I treatment

Report the regulatory capital treatment for the instrument
under the Basel I rule set.

E

Expected Basel III treatment

Report the expected regulatory capital treatment for the
instrument as per Basel III NPR
(https://www.federalregister.gov/articles/2012/08/30/201216757/regulatory-capital-rules-regulatory-capitalimplementation-of-basel-iii-minimum-regulatory-capital).

F

Redemption action

Report the redemption action executed on the instrument.

G

Date on which action was
executed (mm/dd/yyyy)

Report the date on which the redemption/repurchase action
was executed.

H

Notional amount transacted
($Millions)

Report the notional dollar amount by which the instrument
was reduced as a result of the redemption/repurchase action.

I

Regulatory capital amount
transacted ($Millions)

Report the dollar amount of regulatory capital by which the
instrument was reduced as a result of the
redemption/repurchase action.

J

Notional amount remaining at
quarter end ($Millions)

Report the remaining notional dollar amount of the
instrument as of quarter end.

K

Amount recognized in
regulatory capital remaining at
quarter end ($Millions)

Report the remaining dollar amount of the instrument that
was included in regulatory capital as of quarter end.

L

Comments

Use this field to report any supporting information regarding
the instrument.

Do not use this worksheet to report decreases in the amount of any capital instrument that are the
result of amortizations of the remaining balance of the instrument. Any changes due to amortizations of
4

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

instruments that occurred during the quarter should be reflected in the balances of those instruments
as reported on the Regulatory Capital Instruments as of Quarter End worksheet.

Regulatory Capital Instruments Issuances During Quarter worksheet
BHCs are to complete this worksheet with details on any issuances of capital instruments that were
included in regulatory capital during the quarter. For each issued instrument, please provide the
following details:

Column

Heading

Description

B

Committee on Uniform
Securities and Identification
(CUSIP) or unique identifier
provided by BHC

Report the CUSIP number or unique identification number
assigned to the instrument as provided by the BHC

C

Instrument type

Report the type of regulatory capital instrument. Instruments
should be reported based on whether they were actually
included in Tier 1 or Tier 2 regulatory capital.

D

Is issuance result of conversion?

Report whether the issued instrument is the result of a
conversion.

E

If conversion, indicate CUSIP of
original instrument

For issuances that are the result of a conversion, report the
CUSIP of the instrument from which the new issuance was
converted.

F

Date of issuance (mm/dd/yyyy)

Report the date the instrument was issued.

G

Basel I treatment

Report the regulatory capital treatment for the instrument
under the Basel I rule set.

H

Expected Basel III treatment

Report the expected regulatory capital treatment for the
instrument as per Basel III NPR
(https://www.federalregister.gov/articles/2012/08/30/201216757/regulatory-capital-rules-regulatory-capitalimplementation-of-basel-iii-minimum-regulatory-capital).

I

Cumulative/noncumulative

Report whether the instrument’s coupon/dividend is
cumulative or noncumulative.

J

Notional amount transacted
($Millions)

Report the notional dollar amount of the issued instrument.

K

Regulatory capital amount
transacted ($Millions)

Report the dollar amount of the instrument that qualified as
regulatory capital as of quarter end.

5

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

L

Perpetual/dated

Report whether the issued instrument is of fixed maturity
(“dated”) or of no fixed date when capital will be returned to
the investor (“perpetual”).

M

If dated, date of maturity
(mm/dd/yyyy)

For instruments of fixed maturity (i.e., “dated” instruments),
report the maturity date. For “perpetual” instruments, report
“NA”.

N

Issuer call

Report whether there is an issuer call option for the
instrument.

O

If callable, optional call date
(mm/dd/yyyy)

For instruments that feature an issuer call option, report the
first date of call.

P

Fixed/floating

Report whether the instrument has a fixed or floating
coupon/dividend.

Q

Coupon/dividend rate (bps)

For instruments with fixed coupon/dividends, report the
coupon/dividend rate for the instrument. For instruments
that have a floating coupon/dividend or that have neither a
fixed nor floating coupon/dividend rate (such as common
stock), input the coupon/dividend rate paid in the reporting
quarter.

R

Index

For instruments with a coupon/dividend rate that is linked to
the rate of a particular index, report the index to which it is
linked. For instruments with a fixed coupon/dividend rate,
report “NA”.

S

Spread over index (bps)

For instruments with a coupon/dividend rate that is linked to
the rate of a particular index, report the spread over the
relevant index in basis points (e.g., 1M LIBOR+50bps should
be reported as “50”). For instruments that have a fixed
coupon/dividend rate or that have neither a fixed nor floating
coupon/dividend rate, report “NA”.

T

Existence of step up or other
incentive to redeem

Report whether the instrument features a step up or other
incentive to redeem the security. Step–up securities initially
pay the investor an above–market yield for a short period and
then, if not called, ‘‘step up’’ to a higher coupon rate.

U

Convertible/non-convertible

Report whether the instrument is convertible into another
instrument or non–convertible.

V

If convertible, mandatory or
optional conversion?

For instruments that are convertible into another instrument,
report whether the conversion is mandatory or optional. For
non–convertible instruments, report “NA”.

6

FR Y-14A/Q Regulatory Capital Instruments Schedule Instructions

W

If convertible, specify the
instrument type into which it
will convert

For instruments that are convertible into another instrument,
report the type of instrument into which the instrument will
convert. For non–convertible instruments, report “NA”.

X

Comments

Use this field to report any supporting information regarding
the instrument.

Do not use this worksheet to report increases in the amount of any capital instruments that are the
result of accretions that occurred during the quarter. Any changes due to accretions that occurred
during the quarter should be reflected in the balances of those instruments as reported on the
Regulatory Capital Instruments as of Quarter End worksheet.
For all capital instruments except for common stock that were issued during the quarter, please include
as a separate attachment to the schedule submission the prospectus supplement, certificate of
designation, or the indenture for the instrument.
Prior to the issuance of any instruments except for common stock, please provide preliminary
documents related to the issuance to your BHC’s CPC/SSO supervisory team to ensure that the
contractual terms of the instruments meet regulatory capital guidelines. Failure to submit relevant
documents ahead of issuance may lead to risk of issuing an instrument that may not receive the
regulatory capital recognition anticipated by your BHC.

7